262MO Preliminary efficacy outcomes of ivosidenib in patients with IDH1-mutated cholangiocarcinoma (mIDH1 CCA): Initial results from the phase IIIb ProvIDHe study.
Saved in:
| Title: | 262MO Preliminary efficacy outcomes of ivosidenib in patients with IDH1-mutated cholangiocarcinoma (mIDH1 CCA): Initial results from the phase IIIb ProvIDHe study. |
|---|---|
| Authors: | Bridgewater, J.A.1 (AUTHOR), Gardini, A. Casadei2 (AUTHOR), Wilmink, H.3 (AUTHOR), Mercade, T. Macarulla4 (AUTHOR), Sim, H-W.5 (AUTHOR), Verslype, C.6 (AUTHOR), Roderburg, C.7 (AUTHOR), Touchefeu, Y.8 (AUTHOR), McDermott, R.S.9 (AUTHOR), Kordes, M.10 (AUTHOR), Lee, C-K.11 (AUTHOR), Vogel, A.12 (AUTHOR), Kzhdryan, H.G.K.13 (AUTHOR), Vidra, R.A.14 (AUTHOR), Rumpold, H.15 (AUTHOR), Sullivan, A.16 (AUTHOR), Gharbi, H.17 (AUTHOR), Minguez, V. Manuel17 (AUTHOR), Robert, R.17 (AUTHOR), Rimassa, L.18 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 1, Vol. 36, pS103-S103. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 186164151 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 262MO Preliminary efficacy outcomes of ivosidenib in patients with IDH1-mutated cholangiocarcinoma (mIDH1 CCA): Initial results from the phase IIIb ProvIDHe study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Bridgewater%2C+J%2EA%2E%22">Bridgewater, J.A.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gardini%2C+A%2E+Casadei%22">Gardini, A. Casadei</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wilmink%2C+H%2E%22">Wilmink, H.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mercade%2C+T%2E+Macarulla%22">Mercade, T. Macarulla</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sim%2C+H-W%2E%22">Sim, H-W.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Verslype%2C+C%2E%22">Verslype, C.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Roderburg%2C+C%2E%22">Roderburg, C.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Touchefeu%2C+Y%2E%22">Touchefeu, Y.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22McDermott%2C+R%2ES%2E%22">McDermott, R.S.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kordes%2C+M%2E%22">Kordes, M.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lee%2C+C-K%2E%22">Lee, C-K.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Vogel%2C+A%2E%22">Vogel, A.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kzhdryan%2C+H%2EG%2EK%2E%22">Kzhdryan, H.G.K.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Vidra%2C+R%2EA%2E%22">Vidra, R.A.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rumpold%2C+H%2E%22">Rumpold, H.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sullivan%2C+A%2E%22">Sullivan, A.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gharbi%2C+H%2E%22">Gharbi, H.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Minguez%2C+V%2E+Manuel%22">Minguez, V. Manuel</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Robert%2C+R%2E%22">Robert, R.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rimassa%2C+L%2E%22">Rimassa, L.</searchLink><relatesTo>18</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2025 Supplement 1, Vol. 36, pS103-S103. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=186164151 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2025.05.277 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: S103 Titles: – TitleFull: 262MO Preliminary efficacy outcomes of ivosidenib in patients with IDH1-mutated cholangiocarcinoma (mIDH1 CCA): Initial results from the phase IIIb ProvIDHe study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bridgewater, J.A. – PersonEntity: Name: NameFull: Gardini, A. Casadei – PersonEntity: Name: NameFull: Wilmink, H. – PersonEntity: Name: NameFull: Mercade, T. Macarulla – PersonEntity: Name: NameFull: Sim, H-W. – PersonEntity: Name: NameFull: Verslype, C. – PersonEntity: Name: NameFull: Roderburg, C. – PersonEntity: Name: NameFull: Touchefeu, Y. – PersonEntity: Name: NameFull: McDermott, R.S. – PersonEntity: Name: NameFull: Kordes, M. – PersonEntity: Name: NameFull: Lee, C-K. – PersonEntity: Name: NameFull: Vogel, A. – PersonEntity: Name: NameFull: Kzhdryan, H.G.K. – PersonEntity: Name: NameFull: Vidra, R.A. – PersonEntity: Name: NameFull: Rumpold, H. – PersonEntity: Name: NameFull: Sullivan, A. – PersonEntity: Name: NameFull: Gharbi, H. – PersonEntity: Name: NameFull: Minguez, V. Manuel – PersonEntity: Name: NameFull: Robert, R. – PersonEntity: Name: NameFull: Rimassa, L. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 07 Text: 2025 Supplement 1 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 36 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
